Clinical Trial Update: Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years [Phase 3]

View source ↗

Summary

Two-sentence summary: A Phase 3 trial evaluating growth hormone treatment in children born with intrauterine growth restriction (retarded intrauterine growth) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Small For Gestational Age

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Phase 3 | Status: COMPLETED